Yu-Jen Chen
Impact in
- Cancer Research top 2%
- Beetle Biology and Toxicology Studies
- Geriatrics and Gerontology top 2%
Papers in
-
- Beetle Biology and Toxicology Studies 15
-
- Endometrial and Cervical Cancer Treatments 17
- Co-authors
- Hui‐Fen Liao (34 shared papers)Tung‐Hu Tsai (38 shared papers)Ming‐Shi Shiao (4 shared papers)Shengyuan Wang (4 shared papers)Cheng‐Deng Kuo (15 shared papers)Sheng‐Huei Hsiao (3 shared papers)Ming-Ling Hsu (9 shared papers)Chih‐Wen Chi (23 shared papers)
- Journals
- OncoTargets and Therapy (9 papers)Evidence-based Complementary and Alternative Medicine (9 papers)International Journal of Molecular Sciences (9 papers)Oncotarget (7 papers)Anti-Cancer Drugs (7 papers)
- Partner nations
- TaiwanUnited StatesAustralia
In The Last Decade
Yu-Jen Chen
278 papers receiving 8.3k citations
Yu-Jen Chen's Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 830
- Geriatrics and Gerontology 180
- Pharmacology 774
- Epidemiology 1.5k
- Molecular Biology 3.0k
Countries citing papers authored by Yu-Jen Chen
This map shows the geographic impact of Yu-Jen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Jen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Jen Chen more than expected).
Fields of papers citing papers by Yu-Jen Chen
This network shows the impact of papers produced by Yu-Jen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Jen Chen. The network helps show where Yu-Jen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu-Jen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 289 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Hit paper breakdown → | 2021 | 2038 |
| 2 | 2010 | 211 | |
| 3 | 2001 | 176 | |
| 4 | 2020 | 169 | |
| 5 | 1997 | 159 | |
| 6 | 2006 | 142 | |
| 7 | 2001 | 126 | |
| 8 | 2002 | 121 | |
| 9 | 2011 | 104 | |
| 10 | 2019 | 100 | |
| 11 | 2007 | 95 | |
| 12 | 2018 | 93 | |
| 13 | 2002 | 90 | |
| 14 | 2020 | 86 | |
| 15 | Potential role of tetrandrine in cancer therapy. | 2002 | 82 |
| 16 | 2004 | 80 | |
| 17 | 2013 | 78 | |
| 18 | 2008 | 77 | |
| 19 | 2016 | 75 | |
| 20 | 2013 | 73 |
About Yu-Jen Chen
Yu-Jen Chen is a scholar working on Cancer Research, Obstetrics and Gynecology, Oncology, Hepatology and Molecular Biology, having authored 289 papers that have together received 8.5k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (17 papers), Beetle Biology and Toxicology Studies (15 papers), Fungal Biology and Applications (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Autophagy in Disease and Therapy (10 papers), Head and Neck Cancer Studies (9 papers), Cancer Cells and Metastasis (8 papers) and Inflammasome and immune disorders (8 papers). The work is most often cited by research in Cancer Research (830 citations), Geriatrics and Gerontology (180 citations), Pharmacology (774 citations), Epidemiology (1.5k citations) and Molecular Biology (3.0k citations). Yu-Jen Chen has collaborated with scholars based in Taiwan, United States and Australia. Frequent co-authors include Hui‐Fen Liao, Tung‐Hu Tsai, Ming‐Shi Shiao, Shengyuan Wang, Cheng‐Deng Kuo, Sheng‐Huei Hsiao, Ming-Ling Hsu, Chih‐Wen Chi, Chen-Hsi Hsieh and Jie Lee. Their work appears in journals such as OncoTargets and Therapy, Evidence-based Complementary and Alternative Medicine, International Journal of Molecular Sciences, Oncotarget and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.